{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T23:31:32Z","timestamp":1795131092272,"version":"4.10.3"},"reference-count":58,"publisher":"American Society of Hematology","issue":"14","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,7,25]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The genetic mechanisms associated with splenic marginal zone lymphoma (SMZL) transformation are not well defined. We studied 41 patients with SMZL that eventually underwent large B-cell lymphoma transformation. Tumor material was obtained either only at diagnosis (9 patients), at diagnosis and transformation (18 patients), and only at transformation (14 patients). Samples were categorized in 2 groups: (1) at diagnosis (SMZL, n\u00a0= 27 samples), and (2) at transformation (SMZL-T, n\u00a0= 32 samples). Using copy number arrays and a next-generation sequencing custom panel, we identified that the main genomic alterations in SMZL-T involved TNFAIP3, KMT2D, TP53, ARID1A, KLF2, 1q gains, and losses of 9p21.3 (CDKN2A\/B) and 7q31-q32. Compared with SMZL, SMZL-T had higher genomic complexity, and higher incidence of TNFAIP3 and TP53 alterations, 9p21.3 (CDKN2A\/B) losses, and 6p gains. SMZL and SMZL-T clones arose by divergent evolution from a common altered precursor cell that acquired different genetic alterations in virtually all evaluable cases (92%, 12 of 13 cases). Using whole-genome sequencing of diagnostic and transformation samples in 1 patient, we observed that the SMZL-T sample carried more genomic aberrations than the diagnostic sample, identified a translocation t(14;19)(q32;q13) present in both samples, and detected a focal B2M deletion due to chromothripsis acquired at transformation. Survival analysis showed that KLF2 mutations, complex karyotype, and International Prognostic Index score at transformation were predictive of a shorter survival from transformation (P\u00a0= .001; P\u00a0= .042; and P\u00a0= .007; respectively). In summary, SMZL-T are characterized by higher genomic complexity than SMZL, and characteristic genomic alterations that could represent key players in the transformation event.<\/jats:p>","DOI":"10.1182\/bloodadvances.2022009415","type":"journal-article","created":{"date-parts":[[2023,3,30]],"date-time":"2023-03-30T13:01:35Z","timestamp":1680181295000},"page":"3695-3709","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":25,"title":["Unraveling the genetics of transformed splenic marginal zone lymphoma"],"prefix":"10.1182","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3779-0387","authenticated-orcid":false,"given":"Marta","family":"Grau","sequence":"first","affiliation":[{"name":"1Molecular Pathology of Lymphoid Neoplasms, Fundaci\u00f3 Cl\u00ednic per a la Recerca Biom\u00e8dica - Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"L\u00f3pez","sequence":"additional","affiliation":[{"name":"1Molecular Pathology of Lymphoid Neoplasms, Fundaci\u00f3 Cl\u00ednic per a la Recerca Biom\u00e8dica - Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer, Barcelona, Spain"},{"name":"2Universitat de Barcelona, Spain"},{"name":"3Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alba","family":"Navarro","sequence":"additional","affiliation":[{"name":"1Molecular Pathology of Lymphoid Neoplasms, Fundaci\u00f3 Cl\u00ednic per a la Recerca Biom\u00e8dica - Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer, Barcelona, Spain"},{"name":"2Universitat de Barcelona, Spain"},{"name":"3Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6794-6456","authenticated-orcid":false,"given":"Gerard","family":"Frigola","sequence":"additional","affiliation":[{"name":"4Hematopathology Section, Department of Pathology, Hospital Cl\u00ednic de Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2910-9440","authenticated-orcid":false,"given":"Ferran","family":"Nadeu","sequence":"additional","affiliation":[{"name":"1Molecular Pathology of Lymphoid Neoplasms, Fundaci\u00f3 Cl\u00ednic per a la Recerca Biom\u00e8dica - Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer, Barcelona, Spain"},{"name":"3Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2588-7413","authenticated-orcid":false,"given":"Guillem","family":"Clot","sequence":"additional","affiliation":[{"name":"1Molecular Pathology of Lymphoid Neoplasms, Fundaci\u00f3 Cl\u00ednic per a la Recerca Biom\u00e8dica - Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer, Barcelona, Spain"},{"name":"2Universitat de Barcelona, Spain"},{"name":"3Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Bastidas-Mora","sequence":"additional","affiliation":[{"name":"5Department of Hematology, Hospital Cl\u00ednic de Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Alcoceba","sequence":"additional","affiliation":[{"name":"3Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer, Madrid, Spain"},{"name":"6Department of Hematology, Cancer Research Institute of Salamanca, University Hospital of Salamanca, Salamanca, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Joao","family":"Baptista","sequence":"additional","affiliation":[{"name":"7Department of Hematology, Institut Catal\u00e0 d\u2019Oncologia-Hospital Germans Trias i Pujol-Josep Carreras Leukaemia Research Institute, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarita","family":"Blanes","sequence":"additional","affiliation":[{"name":"8Department of Hematology, Hospital General Universitario de Elda, Alicante, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dolors","family":"Colomer","sequence":"additional","affiliation":[{"name":"1Molecular Pathology of Lymphoid Neoplasms, Fundaci\u00f3 Cl\u00ednic per a la Recerca Biom\u00e8dica - Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer, Barcelona, Spain"},{"name":"2Universitat de Barcelona, Spain"},{"name":"3Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer, Madrid, Spain"},{"name":"4Hematopathology Section, Department of Pathology, Hospital Cl\u00ednic de Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dolors","family":"Costa","sequence":"additional","affiliation":[{"name":"1Molecular Pathology of Lymphoid Neoplasms, Fundaci\u00f3 Cl\u00ednic per a la Recerca Biom\u00e8dica - Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer, Barcelona, Spain"},{"name":"3Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer, Madrid, Spain"},{"name":"4Hematopathology Section, Department of Pathology, Hospital Cl\u00ednic de Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8907-090X","authenticated-orcid":false,"given":"Eva","family":"Domingo-Dom\u00e8nech","sequence":"additional","affiliation":[{"name":"9Department of Hematology, Institut Catal\u00e0 d\u2019Oncologia, Hospital Duran i Reynals, Institut d'Investigaci\u00f3 Biom\u00e8dica de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Enjuanes","sequence":"additional","affiliation":[{"name":"3Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer, Madrid, Spain"},{"name":"10Unitat de Gen\u00f2mica, Fundaci\u00f3 Cl\u00ednic per a la Recerca Biom\u00e8dica-Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lourdes","family":"Escoda","sequence":"additional","affiliation":[{"name":"11Department of Hematology, Institut Catal\u00e0 d\u2019Oncologia -Hospital Joan XXIII, Tarragona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Forcada","sequence":"additional","affiliation":[{"name":"12Department of Hematology, Hospital Universitari M\u00fatua Terrassa, Terrassa, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Gin\u00e9","sequence":"additional","affiliation":[{"name":"1Molecular Pathology of Lymphoid Neoplasms, Fundaci\u00f3 Cl\u00ednic per a la Recerca Biom\u00e8dica - Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer, Barcelona, Spain"},{"name":"3Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer, Madrid, Spain"},{"name":"5Department of Hematology, Hospital Cl\u00ednic de Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00f3nica","family":"Lopez-Guerra","sequence":"additional","affiliation":[{"name":"1Molecular Pathology of Lymphoid Neoplasms, Fundaci\u00f3 Cl\u00ednic per a la Recerca Biom\u00e8dica - Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer, Barcelona, Spain"},{"name":"3Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer, Madrid, Spain"},{"name":"4Hematopathology Section, Department of Pathology, Hospital Cl\u00ednic de Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Ram\u00f3n","sequence":"additional","affiliation":[{"name":"13Department of Hematology, Hospital General de Igualada, Igualada, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0385-3415","authenticated-orcid":false,"given":"Alfredo","family":"Rivas-Delgado","sequence":"additional","affiliation":[{"name":"1Molecular Pathology of Lymphoid Neoplasms, Fundaci\u00f3 Cl\u00ednic per a la Recerca Biom\u00e8dica - Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer, Barcelona, Spain"},{"name":"5Department of Hematology, Hospital Cl\u00ednic de Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Vicente Folch","sequence":"additional","affiliation":[{"name":"14Department of Hematology, Consorci Sanitari de Terrassa, Terrassa, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Wotherspoon","sequence":"additional","affiliation":[{"name":"15Department of Histopathology, Royal Marsden NHS Foundation Trust, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4360-8388","authenticated-orcid":false,"given":"Fina","family":"Climent","sequence":"additional","affiliation":[{"name":"16Department of Pathology, Hospital Universitari de Bellvitge-Institut d'Investigaci\u00f3 Biom\u00e8dica de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9850-9793","authenticated-orcid":false,"given":"Elias","family":"Campo","sequence":"additional","affiliation":[{"name":"1Molecular Pathology of Lymphoid Neoplasms, Fundaci\u00f3 Cl\u00ednic per a la Recerca Biom\u00e8dica - Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer, Barcelona, Spain"},{"name":"2Universitat de Barcelona, Spain"},{"name":"3Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer, Madrid, Spain"},{"name":"4Hematopathology Section, Department of Pathology, Hospital Cl\u00ednic de Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armando","family":"L\u00f3pez-Guillermo","sequence":"additional","affiliation":[{"name":"2Universitat de Barcelona, Spain"},{"name":"3Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer, Madrid, Spain"},{"name":"5Department of Hematology, Hospital Cl\u00ednic de Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estella","family":"Matutes","sequence":"additional","affiliation":[{"name":"5Department of Hematology, Hospital Cl\u00ednic de Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7192-2385","authenticated-orcid":false,"given":"S\u00edlvia","family":"Be\u00e0","sequence":"additional","affiliation":[{"name":"1Molecular Pathology of Lymphoid Neoplasms, Fundaci\u00f3 Cl\u00ednic per a la Recerca Biom\u00e8dica - Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer, Barcelona, Spain"},{"name":"2Universitat de Barcelona, Spain"},{"name":"3Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer, Madrid, Spain"},{"name":"4Hematopathology Section, Department of Pathology, Hospital Cl\u00ednic de Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2023,7,18]]},"reference":[{"key":"2023072117400815500_bib1","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Revised","year":"2017","edition":"4th ed."},{"issue":"11","key":"2023072117400815500_bib2","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1182\/blood.2022015851","article-title":"The international consensus classification of mature lymphoid neoplasms: a report from the clinical advisory committee","volume":"140","author":"Campo","year":"2022","journal-title":"Blood"},{"issue":"7","key":"2023072117400815500_bib3","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"issue":"9","key":"2023072117400815500_bib4","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1182\/blood-2010-02-267476","article-title":"Cytogenetic aberrations and their prognostic value in a series of 330 splenic marginal zone B-cell lymphomas: a multicenter study of the Splenic B-Cell Lymphoma Group","volume":"116","author":"Salido","year":"2010","journal-title":"Blood"},{"issue":"2","key":"2023072117400815500_bib5","first-page":"89","article-title":"The (epi)genomic landscape of splenic marginal zone lymphoma, biological implications, clinical utility, and future questions","volume":"5","author":"Jaramillo Oquendo","year":"2021","journal-title":"J\u00a0Transl Genet Genom"},{"issue":"6","key":"2023072117400815500_bib6","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1038\/leu.2013.365","article-title":"Whole-exome sequencing in splenic marginal zone lymphoma reveals mutations in genes involved in marginal zone differentiation","volume":"28","author":"Mart\u00ednez","year":"2014","journal-title":"Leukemia"},{"issue":"6","key":"2023072117400815500_bib7","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1111\/j.1365-2141.2012.09226.x","article-title":"High-throughput sequencing analysis of the chromosome 7q32 deletion reveals IRF5 as a potential tumour suppressor in splenic marginal-zone lymphoma","volume":"158","author":"Fresquet","year":"2012","journal-title":"Br J Haematol"},{"issue":"9","key":"2023072117400815500_bib8","doi-asserted-by":"crossref","first-page":"e44997","DOI":"10.1371\/journal.pone.0044997","article-title":"An integrated genomic and expression analysis of 7q deletion in splenic marginal zone lymphoma","volume":"7","author":"Watkins","year":"2012","journal-title":"PLoS One"},{"issue":"5","key":"2023072117400815500_bib9","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1038\/leu.2014.330","article-title":"KLF2 mutation is the most frequent somatic change in splenic marginal zone lymphoma and identifies a subset with distinct genotype","volume":"29","author":"Clipson","year":"2015","journal-title":"Leukemia"},{"issue":"18","key":"2023072117400815500_bib10","doi-asserted-by":"crossref","first-page":"4174","DOI":"10.1158\/1078-0432.CCR-14-2759","article-title":"Genetics and prognostication in splenic marginal zone lymphoma: revelations from deep sequencing","volume":"21","author":"Parry","year":"2015","journal-title":"Clin Cancer Res"},{"issue":"9","key":"2023072117400815500_bib11","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1084\/jem.20120910","article-title":"Whole-genome sequencing identifies recurrent somatic NOTCH2 mutations in splenic marginal zone lymphoma","volume":"209","author":"Kiel","year":"2012","journal-title":"J\u00a0Exp Med"},{"issue":"9","key":"2023072117400815500_bib12","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1084\/jem.20120904","article-title":"The coding genome of splenic marginal zone lymphoma: Activation of NOTCH2 and other pathways regulating marginal zone development","volume":"209","author":"Rossi","year":"2012","journal-title":"J\u00a0Exp Med"},{"issue":"1","key":"2023072117400815500_bib13","doi-asserted-by":"crossref","first-page":"10444","DOI":"10.1038\/s41598-019-46906-1","article-title":"Systematic review of somatic mutations in splenic marginal zone lymphoma","volume":"9","author":"Jaramillo Oquendo","year":"2019","journal-title":"Sci Rep"},{"issue":"5","key":"2023072117400815500_bib14","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1182\/blood.2021012386","article-title":"Genetic and phenotypic attributes of splenic marginal zone lymphoma","volume":"139","author":"Bonfiglio","year":"2022","journal-title":"Blood"},{"issue":"1","key":"2023072117400815500_bib15","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/bjh.17815","article-title":"Clinico-biological features and outcome of patients with splenic marginal zone lymphoma with histological transformation","volume":"196","author":"Bastidas-Mora","year":"2022","journal-title":"Br J Haematol"},{"issue":"1-2","key":"2023072117400815500_bib16","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.beha.2016.09.005","article-title":"Splenic marginal zone lymphoma","volume":"30","author":"Piris","year":"2017","journal-title":"Best Pract Res Clin Haematol"},{"issue":"8","key":"2023072117400815500_bib17","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.3109\/10428194.2013.861067","article-title":"Long-term follow-up analysis of 100 patients with splenic marginal zone lymphoma treated with splenectomy as first-line treatment","volume":"55","author":"Lenglet","year":"2014","journal-title":"Leuk Lymphoma"},{"issue":"4","key":"2023072117400815500_bib18","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1111\/bjh.13320","article-title":"Outcomes in splenic marginal zone lymphoma: analysis of 107 patients treated in British Columbia","volume":"169","author":"Xing","year":"2015","journal-title":"Br J Haematol"},{"issue":"3","key":"2023072117400815500_bib19","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/sj.leu.2405068","article-title":"Splenic marginal zone lymphoma proposals for a revision of diagnostic, staging and therapeutic criteria","volume":"22","author":"Matutes","year":"2008","journal-title":"Leukemia"},{"issue":"1","key":"2023072117400815500_bib20","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.celrep.2013.12.027","article-title":"Genetics of follicular lymphoma transformation","volume":"6","author":"Pasqualucci","year":"2014","journal-title":"Cell Rep"},{"issue":"11","key":"2023072117400815500_bib21","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1084\/jem.20131448","article-title":"Genetic lesions associated with chronic lymphocytic leukemia transformation to Richter syndrome","volume":"210","author":"Fabbri","year":"2013","journal-title":"J\u00a0Exp Med"},{"issue":"8","key":"2023072117400815500_bib22","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1038\/s41591-022-01927-8","article-title":"Detection of early seeding of Richter transformation in chronic lymphocytic leukemia","volume":"28","author":"Nadeu","year":"2022","journal-title":"Nat Med"},{"issue":"1","key":"2023072117400815500_bib23","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3324\/haematol.2021.278755","article-title":"Marginal zone lymphoma: present status and future perspectives","volume":"107","author":"Cheah","year":"2022","journal-title":"Haematologica"},{"issue":"11","key":"2023072117400815500_bib24","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1093\/annonc\/mdv368","article-title":"Histologic transformation in marginal zone lymphomas","volume":"26","author":"Conconi","year":"2015","journal-title":"Ann Oncol"},{"issue":"34","key":"2023072117400815500_bib25","doi-asserted-by":"crossref","first-page":"3370","DOI":"10.1200\/JCO.18.00138","article-title":"Risk factors for transformation to higher-grade lymphoma and its impact on survival in a large cohort of patients with marginal zone lymphoma from a single institution","volume":"36","author":"Alderuccio","year":"2018","journal-title":"J\u00a0Clin Oncol"},{"issue":"5","key":"2023072117400815500_bib26","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/s41591-018-0016-8","article-title":"Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes","volume":"24","author":"Chapuy","year":"2018","journal-title":"Nat Med"},{"issue":"4","key":"2023072117400815500_bib27","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.ccell.2020.03.015","article-title":"A\u00a0probabilistic classification tool for genetic subtypes of diffuse large b cell lymphoma with therapeutic implications","volume":"37","author":"Wright","year":"2020","journal-title":"Cancer Cell"},{"issue":"20","key":"2023072117400815500_bib28","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1182\/blood.2019003535","article-title":"Targeted sequencing in DLBCL, molecular subtypes, and outcomes: a Haematological Malignancy Research Network report","volume":"135","author":"Lacy","year":"2020","journal-title":"Blood"},{"issue":"15","key":"2023072117400815500_bib29","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1056\/NEJMoa1801445","article-title":"Genetics and pathogenesis of diffuse large b-cell lymphoma","volume":"378","author":"Schmitz","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"2023072117400815500_bib30","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/PAS.0000000000000523","article-title":"NOTCH1, TP53, and MAP2K1 mutations in splenic diffuse red pulp small B-cell lymphoma are associated with progressive disease","volume":"40","author":"Martinez","year":"2016","journal-title":"Am J Surg Pathol"},{"issue":"12","key":"2023072117400815500_bib31","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1038\/sj.leu.2403202","article-title":"Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: Report of the BIOMED-2 Concerted Action BMH4-CT98-3936","volume":"17","author":"van Dongen","year":"2003","journal-title":"Leukemia"},{"issue":"1","key":"2023072117400815500_bib32","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/gcc.22994","article-title":"Balanced and unbalanced translocations in a multicentric series of 2843 patients with chronic lymphocytic leukemia","volume":"61","author":"Costa","year":"2022","journal-title":"Genes Chromosomes Cancer"},{"issue":"4","key":"2023072117400815500_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/gb-2011-12-4-r41","article-title":"GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers","volume":"12","author":"Mermel","year":"2011","journal-title":"Genome Biol"},{"issue":"11","key":"2023072117400815500_bib34","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1002\/gcc.22277","article-title":"Detection of chromothripsis-like patterns with a custom array platform for chronic lymphocytic leukemia","volume":"54","author":"Salaverria","year":"2015","journal-title":"Genes Chromosomes Cancer"},{"issue":"2","key":"2023072117400815500_bib35","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1158\/1078-0432.CCR-20-2558","article-title":"mutational landscape and tumor burden assessed by cell-free DNA in diffuse large b-cell lymphoma in a population-based study","volume":"27","author":"Rivas-Delgado","year":"2021","journal-title":"Clin Cancer Res"},{"issue":"17","key":"2023072117400815500_bib36","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1182\/blood-2015-07-659144","article-title":"Clinical impact of clonal and subclonal TP53, SF3B1, BIRC3, NOTCH1, and ATM mutations in chronic lymphocytic leukemia","volume":"127","author":"Nadeu","year":"2016","journal-title":"Blood"},{"issue":"4","key":"2023072117400815500_bib37","doi-asserted-by":"crossref","first-page":"e1004873","DOI":"10.1371\/journal.pcbi.1004873","article-title":"CNVkit: Genome-wide copy number detection and visualization from targeted DNA sequencing","volume":"12","author":"Talevich","year":"2016","journal-title":"PLoS Comput Biol"},{"issue":"12","key":"2023072117400815500_bib38","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1182\/blood.2020005289","article-title":"Genomic and epigenomic insights into the origin, pathogenesis, and clinical behavior of mantle cell lymphoma subtypes","volume":"136","author":"Nadeu","year":"2020","journal-title":"Blood"},{"issue":"7574","key":"2023072117400815500_bib39","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nature14666","article-title":"Non-coding recurrent mutations in chronic lymphocytic leukaemia","volume":"526","author":"Puente","year":"2015","journal-title":"Nature"},{"issue":"1","key":"2023072117400815500_bib40","doi-asserted-by":"crossref","first-page":"5172","DOI":"10.1038\/s41467-021-25469-8","article-title":"Copy number signatures predict chromothripsis and clinical outcomes in newly diagnosed multiple myeloma","volume":"12","author":"Maclachlan","year":"2021","journal-title":"Nat Commun"},{"issue":"5","key":"2023072117400815500_bib41","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1182\/blood-2010-01-264275","article-title":"Genome-wide DNA profiling of marginal zone lymphomas identifies subtype-specific lesions with an impact on the clinical outcome","volume":"117","author":"Rinaldi","year":"2011","journal-title":"Blood"},{"issue":"13","key":"2023072117400815500_bib42","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1182\/blood-2008-07-170183","article-title":"Uniparental disomies, homozygous deletions, amplifications, and target genes in mantle cell lymphoma revealed by integrative high-resolution whole-genome profiling","volume":"113","author":"Be\u00e0","year":"2009","journal-title":"Blood"},{"issue":"8","key":"2023072117400815500_bib43","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1182\/blood.V91.8.2977.2977_2977_2984","article-title":"p16INK4a gene inactivation by deletions, mutations, and hypermethylation is associated with transformed and aggressive variants of non-hodgkin\u2019s lymphomas","volume":"91","author":"Pinyol","year":"1998","journal-title":"Blood"},{"issue":"12","key":"2023072117400815500_bib44","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1038\/s41379-020-0616-y","article-title":"Evolving insights into the genomic complexity and immune landscape of diffuse large B-cell lymphoma: opportunities for novel biomarkers","volume":"33","author":"el Hussein","year":"2020","journal-title":"Mod Pathol"},{"issue":"2","key":"2023072117400815500_bib45","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.cell.2017.09.027","article-title":"Genetic and functional drivers of diffuse large b cell lymphoma","volume":"171","author":"Reddy","year":"2017","journal-title":"Cell"},{"issue":"12","key":"2023072117400815500_bib46","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1182\/blood-2014-08-596247","article-title":"DNA methylation profiling identifies two splenic marginal zone lymphoma subgroups with different clinical and genetic features","volume":"125","author":"Arribas","year":"2015","journal-title":"Blood"},{"issue":"9","key":"2023072117400815500_bib47","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1182\/blood-2005-04-1399","article-title":"Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene-expression-based survival prediction","volume":"106","author":"Bea","year":"2005","journal-title":"Blood"},{"issue":"22","key":"2023072117400815500_bib48","doi-asserted-by":"crossref","first-page":"9166","DOI":"10.1158\/0008-5472.CAN-10-2460","article-title":"Acquired TNFRSF14 mutations in follicular lymphoma are associated with worse prognosis","volume":"70","author":"Cheung","year":"2010","journal-title":"Cancer Res"},{"issue":"12","key":"2023072117400815500_bib49","doi-asserted-by":"crossref","first-page":"e83244","DOI":"10.1371\/journal.pone.0083244","article-title":"Whole exome sequencing identifies novel recurrently mutated genes in patients with splenic marginal zone lymphoma","volume":"8","author":"Parry","year":"2013","journal-title":"PLoS One"},{"issue":"6","key":"2023072117400815500_bib50","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1182\/blood-2017-08-737361","article-title":"Chromatin modifying gene mutations in follicular lymphoma","volume":"131","author":"Green","year":"2018","journal-title":"Blood"},{"issue":"2","key":"2023072117400815500_bib51","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/leu.2014.294","article-title":"The Kr\u00fcppel-like factor 2 transcription factor gene is recurrently mutated in splenic marginal zone lymphoma","volume":"29","author":"Piva","year":"2015","journal-title":"Leukemia"},{"issue":"1-2","key":"2023072117400815500_bib52","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.beha.2016.09.004","article-title":"Molecular pathogenesis of splenic and nodal marginal zone lymphoma","volume":"30","author":"Spina","year":"2017","journal-title":"Best Pract Res Clin Haematol"},{"issue":"3","key":"2023072117400815500_bib53","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.hemonc.2020.10.003","article-title":"Frequency of MYD88 L256P mutation and its correlation with clinico-hematological profile in mature B-cell neoplasm","volume":"14","author":"Shekhar","year":"2021","journal-title":"Hematol Oncol Stem Cell Ther"},{"issue":"1","key":"2023072117400815500_bib54","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1182\/asheducation-2014.1.113","article-title":"Role of MYD88 in lymphoplasmacytic lymphoma diagnosis and pathogenesis","volume":"2014","author":"Rossi","year":"2014","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"2","key":"2023072117400815500_bib55","doi-asserted-by":"crossref","first-page":"e0212813","DOI":"10.1371\/journal.pone.0212813","article-title":"Unraveling transformation of follicular lymphoma to diffuse large B-cell lymphoma","volume":"14","author":"Gonz\u00e1lez-Rinc\u00f3n","year":"2019","journal-title":"PLoS One"},{"issue":"2","key":"2023072117400815500_bib56","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1038\/leu.2014.209","article-title":"Genomic and epigenomic co-evolution in follicular lymphomas","volume":"29","author":"Loeffler","year":"2015","journal-title":"Leukemia"},{"issue":"2","key":"2023072117400815500_bib57","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/ng.2856","article-title":"Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma","volume":"46","author":"Okosun","year":"2014","journal-title":"Nat Genet"},{"issue":"8","key":"2023072117400815500_bib58","doi-asserted-by":"crossref","first-page":"e310","DOI":"10.3324\/haematol.2016.161711","article-title":"Clinical and diagnostic relevance of NOTCH2-and KLF2-mutations in splenic marginal zone lymphoma","volume":"102","author":"Campos-Mart\u00edn","year":"2017","journal-title":"Haematologica"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/7\/14\/3695\/2065153\/blooda_adv-2022-009415-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/7\/14\/3695\/2065153\/blooda_adv-2022-009415-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,21]],"date-time":"2023-07-21T18:22:56Z","timestamp":1689963776000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/7\/14\/3695\/495159\/Unraveling-the-genetics-of-transformed-splenic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,18]]},"references-count":58,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2023,7,25]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2022009415","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,18]]}}}